<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Obstetrics and Gynecology</journal-id><journal-title-group><journal-title xml:lang="en">Obstetrics and Gynecology</journal-title><trans-title-group xml:lang="ru"><trans-title>Акушерство и гинекология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0300-9092</issn><issn publication-format="electronic">2412-5679</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">336025</article-id><article-id pub-id-type="doi">10.18565/aig.2022.262</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Reviews</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Обзоры</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Search for prognostic markers of the course of endometriosis</article-title><trans-title-group xml:lang="ru"><trans-title>Поиск прогностических маркеров течения эндометриоза</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Levakov</surname><given-names>Sergey A.</given-names></name><name xml:lang="ru"><surname>Леваков</surname><given-names>Сергей Александрович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Med. Sci., Professor, Head of the Department of Obstetrics and Gynecology, N.V. Sklifosovsky Institute of Clinical Medicine</p></bio><bio xml:lang="ru"><p>д.м.н., профессор, заведующий кафедрой акушерства и гинекологии Института Клинической Медицины им. Н.В. Склифосовского</p></bio><email>levakov_s_a@staff.sechenov.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pertseva</surname><given-names>Yulia A.</given-names></name><name xml:lang="ru"><surname>Перцева</surname><given-names>Юлия Андреевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>postgraduate student, Department of Obstetrics and Gynecology, N.V. Sklifosovsky Institute of Clinical Medicine</p></bio><bio xml:lang="ru"><p>аспирант кафедры акушерства и гинекологии Института Клинической Медицины им. Н.В. Склифосовского</p></bio><email>yurchenko_yulya@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Obukhova</surname><given-names>Elizaveta A.</given-names></name><name xml:lang="ru"><surname>Обухова</surname><given-names>Елизавета Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Assistant, Department of Obstetrics and Gynecology, N.V. Sklifosovsky Institute of Clinical Medicine</p></bio><bio xml:lang="ru"><p>ассистент кафедры акушерства и гинекологии Института Клинической Медицины им. Н.В. Склифосовского</p></bio><email>liza_obukhova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Paukov</surname><given-names>Sergey V.</given-names></name><name xml:lang="ru"><surname>Пауков</surname><given-names>Сергей Вячеславович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, Associate Professor, Department of Obstetrics and Gynecology, N.V. Sklifosovsky Institute of Clinical Medicine</p></bio><bio xml:lang="ru"><p>к.м.н., доцент кафедры акушерства и гинекологии Института Клинической Медицины им. Н.В. Склифосовского</p></bio><email>paukov_s_v@staff.sechenov.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bondarenko</surname><given-names>Natalia L.</given-names></name><name xml:lang="ru"><surname>Бондаренко</surname><given-names>Наталья Леонидовна</given-names></name></name-alternatives><bio xml:lang="en"><p>PhD, Chief Physician</p></bio><bio xml:lang="ru"><p>к.м.н., главный врач</p></bio><email>levakov_s_a@staff.sechenov.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5965-8067</contrib-id><name-alternatives><name xml:lang="en"><surname>Shakhparonov</surname><given-names>Mikhail I.</given-names></name><name xml:lang="ru"><surname>Шахпаронов</surname><given-names>Михаил Иванович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD in Chemistry, Leading Researcher at the Laboratory of Membrane and Bioenergetic Systems</p></bio><bio xml:lang="ru"><p>д.х.н., в.н.с. лаборатории мембранных и биоэнергетических систем</p></bio><email>shakhparonov@gmail.com</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Antipova</surname><given-names>Nadezhda V.</given-names></name><name xml:lang="ru"><surname>Антипова</surname><given-names>Надежда Викторовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, Senior Researcher at the Laboratory of Membrane and Bioenergetic Systems; Associate Professor, Department of Pharmaceutical and Toxicological Chemistry</p></bio><bio xml:lang="ru"><p>к.б.н., с.н.с. лаборатории мембранных и биоэнергетических систем; доцент кафедры фармацевтической и токсикологической химии</p></bio><email>Nadine.antipova@gmail.com</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">I.M. Sechenov First Moscow State Medical University (Sechenov University) , Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО «Первый Московский государственный медицинский университет имени И.М. Сеченова» Минздрава России (Сеченовский Университет)</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Clinical Hospital No. 85, Federal Biomedical Agency of Russia</institution></aff><aff><institution xml:lang="ru">ФГБУЗ «Клиническая больница № 85 ФМБА России»</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Academicans M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences</institution></aff><aff><institution xml:lang="ru">ФГБУН «Институт биоорганической химии имени академиков М.М. Шемякина и Ю.А. Овчинникова РАН»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2023-04-18" publication-format="electronic"><day>18</day><month>04</month><year>2023</year></pub-date><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>32</fpage><lpage>36</lpage><history><date date-type="received" iso-8601-date="2023-04-16"><day>16</day><month>04</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-04-16"><day>16</day><month>04</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, ООО «Бионика Медиа»</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/0300-9092/article/view/336025">https://journals.eco-vector.com/0300-9092/article/view/336025</self-uri><abstract xml:lang="en"><p><italic>Endometriosis is regarded as one of the most urgent problems of modern gynecology, whereas its prevalence is about 10% (190 million females) of all reproductive-aged women worldwide. Despite the benign nature of this disease, this process has the features similar to those of malignant diseases, such as loss of cell proliferation control, a tendency for invasive growth, an elevated blood level of cancer-specific markers, and a propensity to relapse.The paper reviews the literature data by Russian and foreign authors, which have been published in the Cochrane Library, Pubmed, and eLibrary databases on the role of the following biomarkers: acetylcholine receptors, matrix metalloproteinases, paraoxonases, bradykinin receptors, and estradiol receptors, in the context of evaluating the course of endometriosis. The increasing role of this disease in the pattern of gynecological diseases, the social significance of the problem, long diagnostic periods, and treatment start since the first symptoms appear generate a need for the medical community to conduct a comprehensive study of this pathology.</italic></p> <p><bold><italic>Conclusion: </italic></bold><italic>Further in-depth study and clarification of the etiopathogenetic mechanisms of endometriosis, as well as the creation of new diagnostic models, will be able to more successfully apply and/or to combine various procedures and methods for treating this disease, developing a modern concept of epigenetic rehabilitation, and improving quality of life in these patients.</italic></p></abstract><trans-abstract xml:lang="ru"><p><italic>Эндометриоз рассматривается как одна из наиболее актуальных проблем современной гинекологии, а его распространенность составляет около 10% (190 млн) среди всех женщин репродуктивного возраста в мире. Несмотря на доброкачественную природу этого заболевания, данный процесс имеет схожие черты со злокачественными заболеваниями, такие как потеря контроля клеточной пролиферации, тенденция к инвазивному росту, повышение уровня онкомаркеров в крови, склонность к рецидивирующему течению.</italic></p> <p><italic>В статье представлен обзор литературных данных отечественных и зарубежных авторов, опубликованных в базах данных Cochrane Library, Pubmed и eLibrary, посвященных роли следующих биомаркеров: ацетилхолиновые рецепторы, матриксные металлопротеиназы, параоксоназы, рецепторы брадикинина, рецепторы эстрадиола в контексте оценки течения эндометриоза. Возрастание роли данного заболевания в структуре гинекологических заболеваний, социальное значение проблемы, длительные сроки постановки диагноза и начала лечения от первых симптомов диктуют медицинскому сообществу необходимость всестороннего изучения этой патологии.</italic></p> <p><bold><italic>Заключение:</italic></bold><italic> Дальнейшее глубокое изучение и уточнение этиопатогенетических механизмов эндометриоза, а также разработка новых диагностических моделей позволят более успешно применять и/или комбинировать различные способы и методы лечения этого заболевания, разработать современную концепцию эпигенетической реабилитации и улучшить качество жизни таких пациенток.</italic></p></trans-abstract><kwd-group xml:lang="en"><kwd>endometriosis</kwd><kwd>endometrioid cystadenoma</kwd><kwd>acetylcholine receptors</kwd><kwd>biomarkers</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>эндометриоз</kwd><kwd>эндометриоидная цистаденома</kwd><kwd>ацетилхолиновые рецепторы</kwd><kwd>биомаркеры</kwd></kwd-group><funding-group><funding-statement xml:lang="en">The investigation has been conducted under Russian Science Foundation Grant “Investigation of the role of cys-loop receptors in the interactions of glioblastoma cells with their microenvironment” under No. 21-74-10092.</funding-statement><funding-statement xml:lang="ru">Работа проведена в рамках гранта Российского научного фонда №21-74-10092: «Исследование роли цис-петельных рецепторов во взаимодействиях клеток глиобластомы с их микроокружением».</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Adamyan L.V. Endometriosis. In.: Sukhikh G.T., Serov V.N., Prilepskaya V.N., Baranov I.I., eds. Gynecology. Pharmacotherapy without errors. Guidelines for physicians. Moscow: E-Noto; 2020: 305-17. (in Russian).</mixed-citation><mixed-citation xml:lang="ru">Адамян Л.В. Эндометриоз. В кн.: Сухих Г.Т., Серов В.Н., Прилепская В.Н., Баранов И.И., ред. Гинекология. Фармакотерапия без ошибок. Руководство для врачей М.: Е-Ното; 2020: 305-17.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><mixed-citation>Gao M., Koupil I., Sjöqvist H., Karlsson H., Lalitkumar S., Dalman C., Kosidou K. Psychiatric comorbidity among women with endometriosis: nationwide cohort study in Sweden.. Am. J. Obstet. Gynecol. 2020; 223(3): 415.e1-415.e16. https://dx.doi.org/10.1016/j.ajog.2020.02.033.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Levakov S.A., Mamedova A.E.K., Azadova G.Y.K., Paukov S.V., Khomeriki T.A., Ilyina O.V. Improving the quality of diagnosis of the spread of ovarian endometriosis. Nat. Volatiles &amp; Essent. Oils. 2021; 8(4): 1761-73.</mixed-citation></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Dubrovina S.O., Berlim Yu.D., Aleksandrina A.D., Vovkochina M.A., Tsirkunova N.S., Bogunova D.Yu. Endometriosis in routine practice: analysis of clinical cases. Obstetrics and Gynecology. 2022; (6): 152-61. (in Russian). https://dx.doi.org/10.18565/aig.2022.6.152-161.</mixed-citation><mixed-citation xml:lang="ru">Дубровина С.О., Берлим Ю.Д., Александрина А.Д., Вовкочина М.А., Циркунова Н.С., Богунова Д.Ю. Эндометриоз в рутинной практике: разбор клинических случаев. Акушерство и гинекология. 2022; 6: 152-61. https://dx.doi.org/10.18565/aig.2022.6.152-161.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><mixed-citation>Zondervan K.T., Becker C.M., Missmer S.A. Endometriosis. N. Engl. J. Med. 2020; 382(13): 1244-56. https://dx.doi.org/10.1056/NEJMra1810764.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Agarwal S.K., Chapron C., Giudice L.C., Laufer M.R., Leyland N., Missmer S.A. et al. Clinical diagnosis of endometriosis: a call to action. Am. J. Obstet. Gynecol. 2019; 220(4): 354.e1-354.e12. https://dx.doi.org/10.1016/j.ajog.2018.12.039.</mixed-citation></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Senina D.N., Chuprynin V.D., Buralkina N.A., Chursin V.V., Smolnova T.Yu., Davidyan L.Yu., Abosov A.S. Main criteria and risk factors for the development of recurrent endometriosis. Obstetrics and Gynecology. 2022; (10): 22-6. (in Russian). https://dx.doi.org/10.18565/aig.2022.10.22-26.</mixed-citation><mixed-citation xml:lang="ru">Сенина Д.Н., Чупрынин В.Д., Буралкина Н.А., Чурсин В.В., Смольнова Т.Ю., Давидян Л.Ю., Абосов А.С. Основные критерии и факторы риска развития рецидива эндометриоза. Акушерство и гинекология. 2022; 10: 22-6. https://dx.doi.org/10.18565/aig.2022.10.22-26.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Lavrukhina M.A. Determination of treatment policy for infertility in patients with ovarian endometrioid cysts. Obstetrics and Gynecology. 2022; (5): 23-9. (in Russian). https://dx.doi.org/10.18565/aig.2022.5.23-29.</mixed-citation><mixed-citation xml:lang="ru">Лаврухина М.А. Определение тактики лечения бесплодия у пациенток с эндометриоидными кистами яичников. Акушерство и гинекология. 2022; 5: 23-9. https://dx.doi.org/10.18565/aig.2022.5.23-29.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><mixed-citation>WHO. Female Genital Tumours. WHO Classification of Tumours, 5th ed., vol. 4, 2020. Available at: https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/Female-Genital-Tumours-2020</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Höhn A.K., Brambs C.E., Hiller G.G.R., May D., Schmoeckel E., Horn L.-C. 2020 WHO Classification of Female Genital Tumors. Geburtshilfe Frauenheilkd. 2021; 81(10): 1145-53. https//dx.doi.org/10.1055/a-1545-4279.</mixed-citation></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Davydov A.I., Mikhaleva L.M., Khabarova M.B., Chilova R.A., Lebedev V.A. Endometrioid cystadenoma – deep ovarian endometriosis. Issues of Gynecology, Obstetrics and Perinatology. 2022; 21(3): 130-7. (in Russian). https://dx.doi.org/10.20953/1726-1678-2022-3-130-137.</mixed-citation><mixed-citation xml:lang="ru">Давыдов А.И., Михалёва Л.М., Хабарова М.Б., Чилова Р.А., Лебедев В.А. Эндометриоидная цистаденома – глубокий яичниковый эндометриоз. Вопросы гинекологии, акушерства и перинатологии. 2022; 21(3): 130-7. https://dx.doi.org/10.20953/1726-1678-2022-3-130-137.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><mixed-citation>Becker C.M., Bokor A., Heikinheimo O., Horne A., Jansen F., Kiesel L. et al; ESHRE Endometriosis Guideline Group. ESHRE guideline: endometriosis. Hum. Reprod. Open. 2022; 2022(2): hoac009. https://dx.doi.org/10.1093/hropen/hoac009.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Hecht J.L., Janikova M., Choudhury R., Liu F., Canesin G., Janovicova L. et al. Labile рeme and heme oxygenase-1 maintain tumor-permissive niche for endometriosis-associated ovarian cancer. Cancers (Basel). 2022; 14(9): 2242. https://dx.doi.org/10.3390/cancers14092242.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Patel B.G., Lenk E.E., Lebovic D.I., Shu Y., Yu J., Taylor R.N. Pathogenesis of endometriosis: Interaction between Endocrine and inflammatory pathways. Best Pract. Res. Clin. Obste.t Gynaecol. 2018; 50: 50-60. https://dx.doi.org/ 10.1016/j.bpobgyn.2018.01.006.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Johnson N.P., Hummelshoj L., Adamson G.D., Keckstein J., Taylor H.S., Abrao M.S. et al.; World Endometriosis Society Sao Paulo Consortium. World Endometriosis Society consensus on the classification of endometriosis. Hum. Reprod. 2017; 32(2):315-24. https://dx.doi.org/10.1093/humrep/dew293.</mixed-citation></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Mezhlumova N.A., Bobrov M.Yu., Adamyan L.V. Biomarkers of endometriosis: problems and possibilities of early detection of disease recurrence (a review). Russian Journal of Human Reproduction. 2018; 24(6): 139 48. (in Russian). https://dx.doi.org/ 10.17116/repro201824061139.</mixed-citation><mixed-citation xml:lang="ru">Межлумова Н.А., Бобров М.Ю., Адамян Л.В. Биомаркеры эндометриоза: проблемы и возможности ранней диагностики рецидивов заболевания. Проблемы репродукции. 2018; 24(6): 139-48. https://dx.doi.org/ 10.17116/repro201824061139.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Bulatova L.S., Solomatina A.A., Kareva E.N., Kotsyubinskaya N.A. Expression of steroid hormone receptors in the tissue of endometriomas in first-time and relapsing patients. Bulletin of RSMU. 2018; (1): 60-4. (in Russian). https://dx.doi.org/10.24075/vrgmu.2018.014.</mixed-citation><mixed-citation xml:lang="ru">Булатова Л.С., Соломатина А.А., Карева Е.Н., Коцюбинская Н.А. Особенности экспрессии генов рецепторов стероидных гормонов в тканях первичных и рецидивирующих эндометриоидных образований яичников. Вестник РГМУ. 2018; 1: 60-4. https://dx.doi.org/10.24075/vrgmu.2018.014.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><mixed-citation>Chen Q., Qu J., Xu Y., Yu Y., Huang X., Zhou L. et al. Expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in ectopic and eutopic endometrium. Zhonghua Fu Chan Ke Za Zhi. 2004; 39(12): 809-12.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Krasnyi A.M., Volgina N.E., Sadekova A.A., Shchpitsyna V.S., Sukhikh G.T., Adamyan L.V., Ozernyuk N.D. Activation of α7-nicotinic acetylcholine receptors causes secretion of matrix metalloproteinases-9 in the human endometrium. Biology Bulletin. 2017; 44: 109-12. https://dx.doi.org/10.1134/S1062359017020078.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Alwazzan A., Mehboob R., Gilani S.A., Mehboob R., Gilani S.A., Hassan A. et al. Immunohistochemical expression of the alpha nicotinic acetylcholine receptor 7 in the human normal, diabetic, and preeclamptic placenta and products of conception. Front. Physiol. 2020; 11: 607239. https://dx.doi.org/10.3389/fphys.2020.607239.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Xu X., Cai X., Liu X., Guo S.W. Possible involvement of neuropeptide and neurotransmitter receptors in Adenomyosis. Reprod. Biol. Endocrinol. 2021; 19(1): 25. https://dx.doi.org/10.1186/s12958-021-00711-6.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Meng X., Li Y., Li Q., Yang J., An M., Fu X. et al. Involvement of bradykinin and bradykinin B1 receptor in patients with endometriosis. Exp. Ther. Med. 2021; 22(5): 1240. https://dx.doi.org/10.3892/etm.2021.10675.</mixed-citation></ref></ref-list></back></article>
